or
forgot password
  • cancer clinical trials in massachusetts

  • Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    North Shore Medical Center Cancer Center

    Trial Locations
    North Shore Medical Center Cancer Center
    Berkshire Hematology Oncology PC
    Commonwealth Hematology Oncology PC-Quincy
    Baystate Medical Center
    University of Massachusetts Medical School
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    DFCI/Children's Hospital of Boston
    Boston, Massachusetts 02114
    Anemia, Aplastic
    AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Boston Medical Center
    Addison Gilbert Hospital
    Cape Cod Hospital
    Holy Family Hospital
    Milford Regional Medical Center
    University of Massachusetts Medical School
    Commonwealth Hematology Oncology PC-Worcester
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Chronic Lymphocytic Leukemia
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    Dana-Farber/Brigham and Women's Cancer Center

    Trial Locations
    Dana-Farber/Brigham and Women's Cancer Center
    South Suburban Oncology Center
    South Shore Hospital
    Cervical Cancer, Endometrial Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Boston University Cancer Research Center
    Hudner Oncology Center at Saint Anne's Hospital - Fall River
    MetroWest Medical Center - Framingham Union Hospital
    Lowell General Hospital
    Prostate Cancer
    Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Massachusetts General Hospital
    UMASS Memorial Cancer Center - University Campus
    Kidney Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Eastern Cooperative Oncology Group
    Boston, Massachusetts 02215
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
    Research Site
    Beverly, Massachusetts
    Melanoma
    AZD1152 in Patients With Advanced Solid Malignancies
    Research Site
    Beverly, Massachusetts
    Tumors
    Continuation of Follow-up of DES-Exposed Cohorts
    New England Medical Center

    Trial Locations
    New England Medical Center
    Boston University School of Public Health
    Diethylstilbestrol (DES) Exposure
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    University of Massachusetts Medical School
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Hodgkin's Lymphoma
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Floating Hospital for Children at Tufts Medical Center
    University of Massachusetts Medical School
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Massachusetts Medical School
    Worcester, Massachusetts 01605
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Computerized and Mailed Reminders in Increasing the Rate of Colorectal Cancer Screening in Adults With an Average Risk for Colorectal Cancer
    Harvard Vanguard Medical Associates - Kenmore

    Trial Locations
    Harvard Vanguard Medical Associates - Kenmore
    Harvard Pilgrim Health Care
    Harvard Medical School
    Colorectal Cancer
    Trial of PTK787/ZK 222584 Plus Paclitaxel
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Metastatic Non-hematologic Malignancies
    SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Colorectal Carcinoma